(Q46205731)
Statements
Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial (English)
Martin G Stoel
Gerard C M Linssen
Clemens von Birgelen
Kenneth Tandjung
Hanim Sen
K Gert van Houwelingen
J Hans W Louwerenburg
Marije M Löwik
Frits H A F de Man
Mark B Nienhuis
Patrick M J Verhorst
Salah A M Saïd